You are here
Healthcare Program: Atrial Fibrillation
ACP, in collaboration with the Heart Rhythm Society, has launched the ACP Advance: Atrial Fibrillation (AF) healthcare program (formerly ACP Quality Connect), which provides participants with the skills to lead practice transformation and QI efforts, resulting in real and meaningful change in AF management and stroke prevention.
The healthcare program takes a collaborative, team-based approach to implement practice transformation and QI strategies that improve care of patients with AF and help prevent stroke. The skills gained through participation can be applied to a number of other clinical conditions and quality challenges. The program offers specialized training in:
- QI and practice transformation methodology
- Identifying and understanding stroke risk in the AF patient
- Engagement of patients in understanding the risks and benefits of anticoagulants
- Developing a treatment plan together with patients to reduce stroke risk
- Assisting patients in managing their own treatment and health
- Integrating use of ACP’s patient tools in practice and treatment workflow
Shared decision-making in Atrial fibrillation
Presented by: Andrew Dunn, MD, MACP, Chief, Division of Hospital Medicine, Mount Sinai Health System, Immediate Past- chair, ACP Board of Regents
The 5 W’s + H of AF Stroke Prevention: Who is at risk, What are the symptoms, Where can AF and stroke occur, When can it occur, Why should I learn more, and How is AF Stroke Prevented
Presented by: Alpesh Amin, MD, MACP
Atrial Fibrillation: Using Quality Improvement to analyze and transform care and management of atrial fibrillation patients
Presented by: Jennie Hsu-Lumetta, MD, FACP, Corinne Kohler, MD, FAAFP, Narain Mandhan, MD, FACP, FAASM and Karen Wiarda, DO
Risk Assessment and Care Coordination for Atrial Fibrillation Patients
Faculty: Bradley P. Knight, MD, FACC, FHRS
ACP Practice Advisor® Stroke Prevention in Atrial Fibrillation Module
An Atrial Fibrillation module has been added to ACP Practice Advisor®. This module, Stroke Prevention in Atrial Fibrillation, addresses three primary strategies for reducing stroke: (1) diagnosis of atrial fibrillation (AF), (2) AF anticoagulation therapy, and (3) referral of complex AF patients for consultation with a cardiologist or electrophysiologist when it is clear that desired patient outcomes are not being met with prescribed therapy. Users of this the Atrial Fibrillation module will be eligible for CME and MOC credit. At the conclusion of this activity, participants will be able to:
- Recognize atrial fibrillation in patients not yet diagnosed with the disorder, including those with comorbidities such as sleep apnea and thyroid disorders
- Apply the CHADS2; CHA2DS2-VASC; and HAS-BLED risk scoring systems to determine appropriate anticoagulation therapy based upon individual risk of stroke and bleeding
- Effectively communicate with patients regarding the pros and cons of different anticoagulation strategies; the risk of stroke and bleeding; and the importance of lifelong adherence to the prescribed therapy
- Refer appropriate patients to a cardiologist or electrophysiologist for consultation as soon as it is clear that desired patient outcomes for rate or rhythm control, symptom relief or stroke risk reduction are not being met with prescribed therapy.
For further information on how to access this module, please contact firstname.lastname@example.org.
Support for ACP’s Atrial Fibrillation initiative is provided by Bristol-Myers Squibb.